🔎 Trials Near Me

Home › Oropharyngeal Cancer › Kansas

Oropharyngeal Cancer clinical trials in Kansas

5 studies for Oropharyngeal Cancer are looking for participants at sites in Kansas.

Cities in Kansas

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

  • University of Kansas Cancer Center, Kansas City
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Westwood Cancer Center, Westwood
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07195734

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

  • University of Kansas Clinical Research Center, Fairway
  • University of Kansas Cancer Center, Kansas City
  • University of Kansas Hospital-Westwood Cancer Center, Westwood
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT05172245

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

  • University of Kansas Cancer Center, Kansas City
  • Salina Regional Health Center, Salina
  • University of Kansas Hospital-Westwood Cancer Center, Westwood
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06532279

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

  • University of Kansas Cancer Center, Kansas City
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT07441681

Integrated Cancer Repository for Cancer Research

  • Saint Luke's Cancer Instititute - South, Overland Park
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.